AWC
REGN icon

Abundance Wealth Counselors’s Regeneron Pharmaceuticals REGN Stock Holding History

Abundance Wealth Counselors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Sell
488
-161
-25% -$110K 0.02% 231
2026
Q1 		$501K Buy
+649
New +$497K 0.07% 144
2021
Q2 		– Sell
-100
Closed -$47K – 282
2021
Q1 		$47K Buy
+100
New +$48.7K 0.01% 172

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Abundance Wealth Counselors's REGN Position: Q2 2026 in Review

Abundance Wealth Counselors reduced its Regeneron Pharmaceuticals (REGN) stake by 25% in Q2 2026, selling an estimated $110K and leaving 488 shares worth $304K. The position accounts for 0.02% of the portfolio, ranked #231.

Abundance Wealth Counselors first reported a position in REGN in Q1 2021 and has held it in 3 quarters since. The position peaked at $501K in Q1 2026. 298 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Abundance Wealth Counselors held 488 shares of Regeneron Pharmaceuticals worth $304K as of Q2 2026.
  • Abundance Wealth Counselors sold 161 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $110K.
  • Regeneron Pharmaceuticals made up 0.02% of Abundance Wealth Counselors's portfolio in Q2 2026, its #231 holding.
  • Abundance Wealth Counselors first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 3 quarters since.
  • Abundance Wealth Counselors's Regeneron Pharmaceuticals position peaked at $501K in Q1 2026.
  • 298 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.